Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-01-31

Study Completion Date

2017-07-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This multicenter prospective trial will evaluate the association between obstructive sleep apnea (OSA) and blood biomarkers in a representative population of consecutively enrolled symptomatic patients with a clinical suspicion of OSA.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Biomarkers for Obstructive Sleep Apnea

NCT00834509

Obstructive Sleep Apnea (OSA)

COMPLETED

Evaluation of Potential Biomarkers for Obstructive Sleep Apnea and the Effect of Positive Pressure Treatment

NCT01976052

Obstructive Sleep Apnea

COMPLETED

Role of Biomarkers to Screen for Obstructive Sleep Apnea

NCT04093102

Obstructive Sleep Apnea

UNKNOWN

The Association Between Obstructive Sleep Apnea Severity and Red Blood Cells Indices

NCT06265129

Obstructive Sleep Apnea

COMPLETED

A Pilot Study of Biomarkers in Obstructive Sleep Apnea

NCT02325687

Obstructive Sleep Apnea

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

OSA

Blood biomarker results in subjects with obstructive sleep apnea.

blood biomarker

Intervention Type DIAGNOSTIC_TEST

Non-OSA

Blood biomarker results in subjects without obstructive sleep apnea

blood biomarker

Intervention Type DIAGNOSTIC_TEST

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

blood biomarker

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written Informed Consent
* Male
* 18-70 years old
* Presentation with symptoms suggestive of obstructive sleep apnea
* Diagnostic sleep study
* Blood draw

Exclusion Criteria

* Prior (within past year) or current therapy for sleep apnea
* Use of opioid pain medication, steroids or allopurinol (within past 30 days)
* Use of chronic anti-inflammatory drugs (within past 7 days)
* Active cancer under current treatment or monitoring

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No